Robert Darflinger, MD

Clinical Instructor
Clinical Fellow

Publications

Alexander MD, Nicholson AD, Darflinger RJ, Settecase F, Cooke DL, Dowd CF, Amans MR, Higashida RT, Hetts SW, Halbach VV. Effects on vessel measurement accuracy and subsequent occlusion after calcium channel blocker infusion during treatment of cerebral aneurysms with the Pipeline embolization device. Interv Neuroradiol. 2017 Feb; 23(1):47-51.
Alexander MD, Halbach V, Nicholson A, Settecase F, Darflinger RJ, Amans MR. Transvenous ethanol sclerotherapy of feeding arteries for treatment of a dural arteriovenous fistula. J Neurointerv Surg. 2017 Mar; 9(3):e12.
Alexander MD, Halbach V, Nicholson A, Settecase F, Darflinger RJ, Amans MR. Transvenous ethanol sclerotherapy of feeding arteries for treatment of a dural arteriovenous fistula. BMJ Case Rep. 2016 Jul 15; 2016.
Darflinger RJ, Chao K. Using the Barrel Technique with the LVIS Jr (Low-profile Visualized Intraluminal Support) Stent to Treat a Wide Neck MCA Bifurcation Aneurysm. J Vasc Interv Neurol. 2015 Jul; 8(3):25-7.
Darflinger R, Thompson LA, Zhang Z, Chao K. Recurrence, retreatment, and rebleed rates of coiled aneurysms with respect to the Raymond-Roy scale: a meta-analysis. J Neurointerv Surg. 2016 May; 8(5):507-11.
Zhao Y, Lin B, Darflinger R, Zhang Y, Holterman MJ, Skidgel RA. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS One. 2009; 4(1):e4226.